- 4-Week # shares sold: 2,972
- 12-Week # shares sold: 4,219
- 24-Week # shares sold: 10,021
One health-care CEO says corporate tax reform would be more meaningful to his company than replacing the Affordable Care Act.
A cancer treatment provider discusses how Washington policies may impact business.
McKesson, Bristol-Myers and Varian were having a busy morning.